BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
94.95
-0.45 (-0.47%)
At close: Mar 28, 2025, 4:00 PM
94.00
-0.95 (-1.00%)
After-hours: Mar 28, 2025, 7:37 PM EDT
BioNTech SE Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for BioNTech SE stock have an average target of 146.17, with a low estimate of 122 and a high estimate of 172. The average target predicts an increase of 53.94% from the current stock price of 94.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 8 | 8 | 9 | 9 | 10 |
Buy | 2 | 3 | 4 | 4 | 4 | 4 |
Hold | 6 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 14 | 15 | 16 | 16 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Initiates $145 | Strong Buy | Initiates | $145 | +52.71% | Mar 13, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $145 → $139 | Buy | Maintains | $145 → $139 | +46.39% | Mar 11, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 | Strong Buy | Maintains | $171 | +80.56% | Mar 11, 2025 |
BMO Capital | BMO Capital | Buy Maintains $130 → $143 | Buy | Maintains | $130 → $143 | +50.61% | Mar 11, 2025 |
Truist Securities | Truist Securities | Strong Buy Initiates $172 | Strong Buy | Initiates | $172 | +81.15% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
2.62B
from 2.75B
Decreased by -4.62%
Revenue Next Year
2.61B
from 2.62B
Decreased by -0.57%
EPS This Year
-4.94
from -2.77
EPS Next Year
-4.85
from -4.94
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.5B | 3.6B | 3.9B | ||
Avg | 2.6B | 2.6B | 3.1B | ||
Low | 1.8B | 1.7B | 2.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 28.7% | 38.3% | 47.8% | ||
Avg | -4.6% | -0.6% | 17.2% | ||
Low | -35.4% | -34.0% | -17.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.73 | -1.18 | -0.20 | ||
Avg | -4.94 | -4.85 | -5.01 | ||
Low | -7.60 | -8.70 | -9.32 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.